Hemizygous contiguous gene deletion within Xq28 that includes BCAP31, ABCD1, SRPK3 and SSR4: case report and literature review

Joan Chern-Hui Lien , Vinay D. Chandrasekaran , Tarachandra M. Narumanchi , Melissa S. Napoli , Jo Elle G. Peterson , Charles A. Williams

Global Medical Genetics ›› 2025, Vol. 12 ›› Issue (03) : 100066

PDF (972KB)
Global Medical Genetics ›› 2025, Vol. 12 ›› Issue (03) :100066 DOI: 10.1016/j.gmg.2025.100066
Case report
research-article
Hemizygous contiguous gene deletion within Xq28 that includes BCAP31, ABCD1, SRPK3 and SSR4: case report and literature review
Author information +
History +
PDF (972KB)

Abstract

We report on a rare 110 kilobase contiguous gene deletion within chromosome region Xq28, encompassing 7 annotated Online Mendelian Inheritance in Man (OMIM) genes and extending from BCAP31 to the telomeric-located PDZD4. We review 13 other reported contiguous deletions in this region and analyze their clinical phenotypes. The novel findings in our case were orofacial clefting and a vascular ring. The major clinical anomalies in our case appear to be due to the combined effects of BCAP31, SRPK3 and SSR4 deletions. This combination produces a severe neonatal disorder whose features further refine our knowledge about deletions within Xq28. Additionally, the observation of multiple nonrecurring breakpoints among the published cases suggests that the deletions occur by random chromosome breakage.

Keywords

Contiguous gene deletion / Xq28 / X chromosome / Microarray

Cite this article

Download citation ▾
Joan Chern-Hui Lien, Vinay D. Chandrasekaran, Tarachandra M. Narumanchi, Melissa S. Napoli, Jo Elle G. Peterson, Charles A. Williams. Hemizygous contiguous gene deletion within Xq28 that includes BCAP31, ABCD1, SRPK3 and SSR4: case report and literature review. Global Medical Genetics, 2025, 12(03): 100066 DOI:10.1016/j.gmg.2025.100066

登录浏览全文

4963

注册一个新账户 忘记密码

Conflicts of interest

None of the authors declare Financial and Non-Financial Relationships and Activities, and Conflicts of Interest regarding this manuscript.

References

[1]

G.V. Raymond, A.B. Moser, Fatemi A. X-linked adrenoleukodystrophy, in: M. P. Adam, J. Feldman, G.M. Mirzaa, R.A. Pagon, S.E. Wallace, L.J.H. Bean, et al. (Eds.), GeneReviews((R)). Seattle (WA), 1993.

[2]

D. Corzo, W. Gibson, K. Johnson, G. Mitchell, G. LePage, G.F. Cox, et al., Contiguous deletion of the X-linked adrenoleukodystrophy gene (ABCD1) and DXS1357E: a novel neonatal phenotype similar to peroxisomal biogenesis disorders, Am. J. Hum. Genet 70 (6) (2002) 1520-1531.

[3]

J.M. van de Kamp, A. Errami, M. Howidi, I. Anselm, S. Winter, J. Phalin-Roque, et al., Genotype-phenotype correlation of contiguous gene deletions of SLC6A8, BCAP31 and ABCD1, Clin. Genet 87 (2) (2015) 141-147.

[4]

P. Cacciagli, J. Sutera-Sardo, A. Borges-Correia, J.C. Roux, I. Dorboz, J.P. Desvignes, et al., Mutations in BCAP 31 cause a severe X-linked phenotype with deafness, dystonia, and central hypomyelination and disorganize the Golgi apparatus, Am. J. Hum. Genet 93 (3) (2013) 579-586.

[5]

B. Rinaldi, E. Van Hoof, A. Corveleyn, A. Van Cauter, T. de Ravel, BCAP31-related syndrome: the first de novo report, Eur. J. Med Genet 63 (2) (2020) 103732.

[6]

S. Whalen, M. Shaw, C. Mignot, D. Heron, S.C. Bastaraud, C.C. Walti, et al., Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants, Eur. J. Hum. Genet 29 (9) (2021) 1405-1417.

[7]

M. Iwasa, T. Yamagata, M. Mizuguchi, M. Itoh, A. Matsumoto, M. Hironaka, et al., Contiguous ABCD1 DXS1357E deletion syndrome: report of an autopsy case, Neuropathology 33 (3) (2013) 292-298.

[8]

OMIM, online Mendelian Inheritance in Man: Contiguous ABCD1/DXS1375E deletion syndrome;CADDS, included, 300475, Date last edited 12-28- 2015 Johns Hopkins University, Baltimore, MD; 2015 [Available from: 〈 https://omim.org/entry/300475〉.

[9]

Z. Lynton, R. Suarez, L.R. Fenlon, Brain plasticity following corpus callosum agenesis or loss: a review of the probst bundles, Front Neuroanat. 17 (2023) 1296779.

[10]

G. Ghosh, J.A. Adams, Phosphorylation mechanism and structure of serine-arginine protein kinases, FEBS J. 278 (4) (2011) 587-597.

[11]

A. Roychaudhury, Y.R. Lee, T.I. Choi, M.G. Thomas, T.N. Khan, H. Yousaf, et al., SRPK 3 Is Essential for cognitive and ocular development in humans and zebrafish, explaining X-linked intellectual disability, Ann. Neurol. (2024)

[12]

C. Johnsen, N. Tabatadze, S. Radenkovic, G. Botzo, B. Kuschel, G. Melikishvili, et al., SSR4-CDG, an ultra-rare X-linked congenital disorder of glycosylation affecting the TRAP complex: review of 22 affected individuals including the first adult patient, Mol. Genet Metab. 142 (3) (2024) 108477.

[13]

C. Castiglioni, F. Feillet, C. Barnerias, A. Wiedemann, J. Muchart, F. Cortes, et al., Expanding the phenotype of X-linked SSR4-CDG: connective tissue im-plications, Hum. Mutat. 42 (2) (2021) 142-149.

[14]

B.G. Ng, K. Raymond, M. Kircher, K.J. Buckingham, T. Wood, J. Shendure, et al., Expanding the molecular and clinical phenotype of SSR4-CDG, Hum. Mutat. 36 (11) (2015) 1048-1051.

[15]

I.A. Anselm, F.S. Alkuraya, G.S. Salomons, C. Jakobs, A.B. Fulton, M. Mazumdar, et al., X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype, J. Inherit. Metab. Dis. 29 (1) (2006) 214-219.

[16]

T. Matsumoto, N. Miyake, Y. Watanabe, G. Yamanaka, S. Oana, M. Ogiwara, et al., X-linked adrenoleukodystrophy with partial deletion of ALD due to fusion with the neighbor gene, PLXNB3, Am. J. Med Genet A 138A ( 3) (2005) 300-302.

[17]

H. Osaka, A. Takagi, Y. Tsuyusaki, T. Wada, M. Iai, S. Yamashita, et al., Contiguous deletion of SLC6A8 and BAP 31 in a patient with severe dystonia and sensorineural deafness, Mol. Genet Metab. 106 (1) (2012) 43-47.

[18]

L. Weng, Q. Deng, X. Chen, K. Wang, J. Shao, [A case of congenital disorder of glycosylation due to SSR4 gene deletion], Zhonghua Yi Xue Yi Chuan Xue Za Zhi 40 (3) (2023) 364-367.

[19]

I.J. Chang, M. He, C.T. Lam, Congenital disorders of glycosylation, Ann. Transl. Med 6 (24) (2018) 477.

[20]

D. De Graef, A.N. Ligezka, J. Rezents, G.L. Mazza, G. Preston, K. Schwartz, et al., Coagulation abnormalities in a prospective cohort of 50 patients with PMM2- congenital disorder of glycosylation, Mol. Genet Metab. 139 (2) (2023) 107606.

[21]

B. Pasternak, A. Hviid, Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects, JAMA 304 (8) (2010) 859-866.

[22]

O. Skare, H.K. Gjessing, M. Gjerdevik, O.A. Haaland, J. Romanowska, R.T. Lie, et al., A new approach to chromosome-wide analysis of X-linked markers identifies new associations in Asian and European case-parent triads of orofacial clefts, PLoS One 12 (9) (2017) e0183772.

[23]

L. Tamagnone, S. Artigiani, H. Chen, Z. He, G.I. Ming, H. Song, et al., Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates, Cell 99 (1) (1999) 71-80.

[24]

D. Rujescu, E.M. Meisenzahl, S. Krejcova, I. Giegling, T. Zetzsche, M. Reiser, et al., Plexin B 3 is genetically associated with verbal performance and white matter volume in human brain, Mol. Psychiatry 12 (2) (2007) 190-194 15.

[25]

Z. Feng, X. Chen, T. Li, H. Gao, W. Chen, Y. Gao, et al., An X-linked PLXNB 3 mutation identified in patients with congenital heart disease with neurodeve-lopmental disabilities, Transl. Pedia 11 (11) (2022) 1852-1863.

[26]

V. Brenner, G. Nyakatura, A. Rosenthal, M. Platzer,Genomic organization of two novel genes on human Xq28: compact head to head arrangement of IDH gamma and TRAP delta is conserved in rat and mouse, Genomics 44 (1) (1997) 8-14.

[27]

M. Katoh, M. Katoh, Identification and characterization of human PDZRN4L gene and mouse Pdzrn4l gene in silico, Int J. Mol. Med 13 (6) (2004) 923-927.

[28]

C. Giovenino, S. Trajkova, L. Pavinato, S. Cardaropoli, V. Pullano, E. Ferrero, et al., Skewed X-chromosome inactivation in unsolved neurodevelopmental disease cases can guide re-evaluation for X-linked genes, Eur. J. Hum. Genet 31 (11) (2023) 1228-1236.

[29]

A. Piton, J. Gauthier, F.F. Hamdan, R.G. Lafreniere, Y. Yang, E. Henrion, et al., Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia, Mol. Psychiatry 16 (8) (2011) 867-880.

[30]

OMIM, online Mendelian Inheritance in Man: Congenital disorder of glycosylation, type Iy; CDG1Y, 300934: edit date: 07-29-2024: Johns Hopkins University, Baltimore, MD.; 2024 [Available from: World Wide Web URL: 〈 https://omim.org/entry/300934〉].

[31]

R.A. Shah, B. Asatryan, G. Sharaf Dabbagh, N. Aung, M.Y. Khanji, L.R. Lopes, et al. Frequency, penetrance, and variable expressivity of dilated cardiomyopathy- associated putative pathogenic gene variants in UK biobank participants, Circulation 146 (2) (2022) 110-124.

[32]

O. Akinrinade, J.W. Koskenvuo, T.P. Alastalo, Prevalence of titin truncating variants in general population, PLoS One 10 (12) (2015) e0145284.

PDF (972KB)

26

Accesses

0

Citation

Detail

Sections
Recommended

/